Swang Chai Chuan Limited reports higher interim revenue and profit for the period. The company announces it will not distribute a dividend despite improved financial performance.
Holista and SCC, two Malaysian companies, partner to compete in the global collagen market, traditionally led by Western firms. The collaboration aims to expand their presence in an industry dominated by established international players. The move highlights a strategic push by Southeast Asian firms into high-value biotech sectors.
Holista Colltech partners with Swang Chai Chuan (SCC) to develop and operate an ovine nano-collagen production facility in Collie, Western Australia. The collaboration involves funding, construction, and management of the facility. This joint venture aims to expand production capabilities for nano-collagen derived from sheep sources.
Holista Colltech Limited has entered a binding joint venture agreement to develop a collagen production facility named **Collie**. The partnership involves Swang Chai, though specific terms or facility details remain undisclosed. The collaboration aims to advance Holista’s collagen-based product pipeline, leveraging the facility’s capacity for research and manufacturing.
Swang Chai Chuan Limited partners in a joint venture to develop an ovine nano-collagen production facility in Australia. The collaboration focuses on leveraging nano-collagen derived from sheep for potential applications in biotechnology and health industries.